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Gastric cancer is one of the most common malignant tumors. Its occurrence and development are closely associated with the inactivation of a variety of tumor suppressor genes (TSGs). CHFR, a TSG, is discovered by Scolnick . 1 in 2000 that can be used to detect the phase and control the process of cell division. It is found that CHFR gene is universally expressed in normal gastric tissues, but not in gastric cancer tissues 2, 3 . Abnormal methylation of CHFR gene is the main cause for its transcriptional silencing, which is relevent with the occurrence and development of tumor 4, 5 . Previous studies 6,7 used methylation specific polymerase chain reaction (MSP) and combined bisulfite restriction analysis (COBRA) to detect the methylation status of CHFR gene promoter region in gastric cancer patients, respectively. It is not reported, however, whether there are differences between these two methods. In our study, we used both MSP and COBRA to detect the methylation status of CHFR gene in gastric cancer, analyzed its possible role in gastric cancer occurrence and its relationship with clinicopathologic features of gastric cancer, and compared the detection rate of CHFR gene methylation in gastric cancer tissues between these two methods.
Sixtyfour patients with primary gastric cancer diagnosed by pathologic examination and treated by surgical operation in Anhui Genomic DNA was extracted by DNA extraction kit according to the kit instruction. DNA concentration was measured by UV spectrophotometry, then DNA was stored at 20益 temporarily.
DNA was modified by onestep methylation kit according to the kit instruction. After modification, DNA was recovered by ethanol precipitation and resuspended in de鄄 ionized water, which is used for MSP and COBRA detection.
Targeting at the regulatory region of CHFR gene promoter, the PCR primers were designed according to literature. 8 Primer sequences and annealing temperatures are shown in Table 1 . MSP reaction system was 25 滋 L, including 10 伊 PCR buffer, 1.5 mmol/L of MgCl 2 , 10 mmol/L of dNTP, 0.5 mmol/L of upstream and downstream primers, and 1 U of Taq DNA polymerase. The DNA templates of methylation positive control were obtaind from methylase Sss Imodified normal human peripheral blood DNA while nonmethylation positive control from the unmodified one. Water, instead of template, was used as blank control. When PCR was completed, 10 滋 L of product was taken and mixed with 6 伊 loading buffer, added with 1.5% agarose gel for electrophoresis and EB staining. Electrophoresis results were recorded and analyzed by image collection and analysis system.
The MSPdetected positive samples were tested by COBRA.
9 CHFR gene primers for COBRA amplification were designed according to literature.
7
Primer sequences, reaction conditions and annealing temperatures are shown in Table 1 . PCR system and components used in COBRA were the same as those in MSP. PCR products were purified by DNA purification kit according to the kit instruction. After purification, the PCR products were digested by endonuclease BstU I in 60℃ water bath for 6 h. The DNA templates for positive control were obtained from methylase Sss Imodified normal human peripheral blood DNA. After water bath, 10 滋 L of product was taken and mixed with 6 伊 loading buff er, added with 3.0% agarose gel for The data of CHFR gene methylation frequency was compared by the Chisquare test using SPSS16.0 software package. A value of < 0.05 was considered significant.
Using specific primers, corresponding bands of methylation and nonmethylation positive controls of CHFR gene were amplified by MSP, and no other bands existed, with no bands in blank control amplification (Figure 1) , indicating that the experiment techniques, the primers and reagents were proper A B M, methylated specific primers; U, unmethylated specific primers; F, forward primer; R, reverse primer. and the results were reliable. The abnormal methylation rate of CHFR gene was 51.6% in gastric cancer tissues and 18.8% in adjacent normal tissues, with significant difference ( < 0.001).
The abnormal methylation of CHFR gene promoter in gastric cancer tissues showed no relationship with patients爷 age, gender, tumor size, pathologic stage, Borrman type, tumor invasion depth, tissue differentiation degree and lymph node metastasis ( > 0.05) ( Table 2 ).
The methylation rates of CHFR in the 64 specimens of gastric cancer were 42.2% when detected by COBRA and 51.6% by MSP, with no statistical difference ( > 0.05). Among the 33 specimens of MSPdetected methylationpositive gastric cancer tissues, 27 were positive and 6 were negative (that is, false positive) when detected by COBRA; all the 31 specimens of MSPdetected methylationnegative gastric cancer tissues were negative when detected by COBRA (Figures 2 and 3) .
Hypermethylation of TSGs is an important pathogenic factor of tumor and is a frequent early event in tumorigenesis. The occurrence and development of gastric cancer is an accumulating abnormal process involving multiple factors, stages and genes. Up till now, abnormal methylation of a variety of TSGs have been detected in gastric cancer 10, 11 . Meanwhile, it is reported that CHFR gene is silenced due to abnormal methylation of its promoter. Morioka . 3 found that 16 (30% ) out of 53 primary gastric cancer tissues had CHFR gene promoter abnormally methylated. Koga . 12 found that abnormal methylation rate of CHFR gene promoter in gastric cancer tissue was 52% (24/46). Gao et al.[6] found that CHFR gene promoter was methylated in 9 (45% ) out of 20 gastric cancer tissues while none in the paired 20 nontumor tissues ( < 0.001), and CHFR methylation was associated with the differentiation degree of gastric cancer. Additionally, Homma . 13 found that CHFR gene promoter methylation was associated with the degree of malignancy of gastric cancer. The above results indicated that CHFR gene promoter methylation was a frequent event in gastric cancer and 
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might be associated with clinicopathologic features. Other studies 7, 14 reported that after treatment with certain drugs (such as 5aza2'deoxycytidine), hypermethylationcaused deficient CHFR gene expression could be restored, the functions of some check points could be recovered and methylationsilenced genes could be reactivated, indicating that detecting the methylation of CHFR gene promoter might be helpful to judge the treatment outcomes of gastric cancer and monitor the prognosis of the patients.
Our study found that the abnormal methylation rate of CHFR gene in gastric cancer tissues was significantly higher than that in adjacent normal tissues, indicating that abnormal methylation of CHFR gene might be involved in the occurrence and development of gastric cancer, but it had no relationships with the clinicopathologic features of gastric cancer ( > 0.05), including patient's age, gender, tumor size, pathologic stage, Borrman type, tumor invasion depth, tissue differentiation degree and lymph node metastasis. In our study, the methylation rate of CHFR gene in gastric cancer tissues was consistent with 52% in reference 12 , while different from those in references 3, 6 , which might due to different methylation specific primers applied in researches, as well as heterogeneous or incomplete methylation of CpG sites in the CHFR gene promoter.
In our study, we detected the methylation of CHFR gene in gastric cancer tissues using both MSP and COBRA, colligated the advantages of the high sensitivity of MSP and high specificity of COBRA, guaranteed the accuracy of the results. We investigated the difference in detecting CHFR gene methylation in gastric cancer tissues between the two methods and found it was not significant. However, COBRA had a relatively high specificity in methylation detection, being able to detect the false positive results in MSP. Therefore, for methylation detection in large quantity, we could first use MSP, then use COBRA to exclude the false positive results in MSP. In our study, we did not find a case that was positive in COBRA while negative in MSP, which might due to the relative small sample size. Further study with enlarged sample size might lead to a more comprehensive conclusion.
In summary, detecting CHFR gene promoter methylation in gastric cancer tissues might be helpful to the diagnosis. In addition, detecting CHFR gene methylation by both MSP and COBRA might be helpful to improve the accuracy of test results.
